Bicocca Open Archive

Logo unimib boa
FRUSCIO, ROBERT
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.983
AS - Asia 18.517
EU - Europa 12.322
SA - Sud America 2.681
AF - Africa 454
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 26
Totale 59.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.299
SG - Singapore 6.408
CN - Cina 3.786
VN - Vietnam 2.876
IT - Italia 2.685
HK - Hong Kong 2.501
RU - Federazione Russa 2.026
BR - Brasile 1.940
DE - Germania 1.326
IE - Irlanda 1.177
SE - Svezia 1.057
FR - Francia 768
GB - Regno Unito 746
UA - Ucraina 711
IN - India 528
CA - Canada 405
FI - Finlandia 383
ID - Indonesia 364
KR - Corea 305
TR - Turchia 293
ES - Italia 281
BD - Bangladesh 247
AR - Argentina 246
NL - Olanda 230
AT - Austria 210
JP - Giappone 208
IQ - Iraq 193
MX - Messico 188
ZA - Sudafrica 138
CO - Colombia 131
SA - Arabia Saudita 117
PL - Polonia 111
PH - Filippine 103
PK - Pakistan 103
EC - Ecuador 96
DK - Danimarca 92
CH - Svizzera 84
VE - Venezuela 77
BE - Belgio 71
CL - Cile 66
CZ - Repubblica Ceca 66
MA - Marocco 63
EG - Egitto 59
AU - Australia 57
UZ - Uzbekistan 52
TH - Thailandia 48
AE - Emirati Arabi Uniti 45
GR - Grecia 43
PE - Perù 43
RO - Romania 42
KE - Kenya 41
PY - Paraguay 39
MY - Malesia 38
PT - Portogallo 38
TN - Tunisia 36
IR - Iran 33
SK - Slovacchia (Repubblica Slovacca) 30
JO - Giordania 27
UY - Uruguay 27
LT - Lituania 25
IL - Israele 24
ET - Etiopia 22
JM - Giamaica 22
NP - Nepal 22
BG - Bulgaria 21
DZ - Algeria 20
KZ - Kazakistan 20
PS - Palestinian Territory 19
LB - Libano 18
AZ - Azerbaigian 17
TW - Taiwan 17
AL - Albania 16
OM - Oman 16
EU - Europa 15
LV - Lettonia 15
RS - Serbia 15
SN - Senegal 15
CR - Costa Rica 14
HN - Honduras 12
HU - Ungheria 11
KH - Cambogia 10
KW - Kuwait 10
LK - Sri Lanka 10
BO - Bolivia 9
CI - Costa d'Avorio 9
NG - Nigeria 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BA - Bosnia-Erzegovina 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
MD - Moldavia 8
AO - Angola 7
BH - Bahrain 7
GE - Georgia 7
GT - Guatemala 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
BY - Bielorussia 6
GY - Guiana 6
PA - Panama 6
Totale 58.936
Salva come PNG Salva come JPEG
Città #
Singapore 3.658
Ann Arbor 3.294
Ashburn 2.446
Hong Kong 2.439
Woodbridge 1.570
Fairfield 1.493
San Jose 1.344
Dublin 1.119
Houston 1.096
Chandler 948
Ho Chi Minh City 867
Wilmington 825
Hanoi 696
Jacksonville 694
Frankfurt am Main 675
New York 650
Seattle 649
Hefei 604
Milan 595
Santa Clara 559
Cambridge 520
Chicago 494
Dearborn 489
Dallas 483
Los Angeles 470
The Dalles 441
Princeton 426
Beijing 423
Seoul 279
Lauterbourg 272
Jakarta 266
Hangzhou 224
Moscow 218
Nanjing 212
Shanghai 195
Lawrence 191
Buffalo 183
Council Bluffs 183
Altamura 170
São Paulo 169
Boardman 165
Helsinki 164
Vienna 144
Rome 131
Tokyo 128
Lachine 112
Nuremberg 112
San Diego 109
Da Nang 108
London 108
Guangzhou 104
Munich 90
Haiphong 89
Lissone 85
Orem 83
Nanchang 79
Baghdad 77
Toronto 77
Chennai 74
Johannesburg 68
Brooklyn 67
Istanbul 67
Atlanta 66
Montreal 64
Ottawa 64
Warsaw 64
Rio de Janeiro 63
Andover 62
Lappeenranta 61
Amsterdam 58
Shenyang 57
Dong Ket 56
Denver 53
Fremont 52
Brno 50
Changsha 50
Kent 48
Salt Lake City 48
Biên Hòa 47
Manchester 46
Dhaka 45
Hải Dương 45
Jinan 45
Ankara 44
Hebei 44
Tashkent 44
Zurich 44
Brussels 42
Poplar 42
Belo Horizonte 41
Mexico City 41
Mumbai 41
Phoenix 41
Riyadh 41
Ninh Bình 40
Brasília 39
Columbus 39
Tianjin 39
Kunming 38
Porto Alegre 38
Totale 36.612
Salva come PNG Salva come JPEG
Nome #
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 1.036
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 946
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 560
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 528
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 524
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 466
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 456
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations 452
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 438
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 427
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 420
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 393
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 383
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 383
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 365
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 361
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 359
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 357
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 350
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 345
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 340
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 337
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 331
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 325
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 323
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 318
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 317
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 315
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 315
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 314
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 303
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 301
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 298
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 296
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 295
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 293
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 290
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 290
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 287
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 286
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 286
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 285
Delaying surgery for patients with a previous SARS-CoV-2 infection 280
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 276
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 274
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 274
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 269
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 269
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 263
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 262
Synchronous early-stage endometrial and ovarian cancer 261
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 259
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study 255
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 255
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 253
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 252
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 252
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 251
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 250
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 248
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 246
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 245
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 243
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 243
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 241
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 241
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 241
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 240
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 239
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 238
Association between physical activity and menstrual cycle disorders in young athletes 237
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 237
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause 235
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 235
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 235
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 233
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 232
Borderline ovarian cancer 231
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 230
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 230
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 229
PRL-3 phosphatase is implicated in ovarian cancer growth 228
Managing Ovarian tumors during pregnancy 228
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 227
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 227
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 225
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 224
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 223
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 221
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 220
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 219
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 218
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 218
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 217
An exploration of body image distress in women who underwent a prophylactic bilateral salpingo-oophorectomy (PBSO) 216
Fertility outcomes in stage I ovarian immature teratomas 215
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 214
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery 212
The role of transvaginal ultrasound in the workup of invasive molar disease 211
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 211
Totale 30.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.002 0 0 0 0 0 0 0 0 0 424 226 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/202511.485 583 1.228 523 532 901 610 604 537 1.227 1.683 1.027 2.030
2025/202623.081 3.093 2.037 1.923 2.581 2.816 1.364 3.485 1.323 2.085 2.374 0 0
Totale 60.414